Püren Gökbulut
Püren Gökbulut has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Işılay Taşkaldıran
Department of Endocrinology and Metabolic Diseases, Ankara Training and Research Hospital, Ankara, Turkey
5 shared publications - Volkan Gökbulut
Department of Gastroenterology, Ankara City Hospital, Ankara, Turkey
5 shared publications Gonul Koc
Department of Endocrinology and Metabolic Diseases, Ankara Training and Research Hospital
4 shared publications- Çağatay Emir Önder
Ankara Eğitim ve Araştırma Hastanesi
4 shared publications Cagatay Emir Onder
Department of Endocrinology and Metabolic Diseases, Ankara Training and Research Hospital
3 shared publications- Gönül Koç
Department of Endocrinology and Metabolism, Ankara Training and Research Hospital, Ankara, Türkiye
3 shared publications
Latest Publications
- 12 August 2026
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 28 (2) , 341-350
FIB-4 INDEX IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: A CASE-CONTROL STUDY
Objective: Although the target organs for primary hyperparathyroidism (PHPT) are the renal and skeletal systems, hyperparathyroidism has also been linked with metabolic syndrome as well as non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate metabolic parameters, and the fibrosis-4 index (FIB-4) among patients with PHPT. Material and Methods: This study included 30 patients with PHPT and 30 healthy controls. FIB-4 index was calculated for all participants whose metabolic parameters were recorded. In addition, according to the FIB-4 index, participants were divided into low and medium-high risk categories for fibrosis using a cut-off value of 1.3. The participants’ metabolic parameters and the FIB-4 indices were compared. Results: PHPT patients had a median age of 58 years (25–65), and 90% of them were female. Metabolic parameters (fasting plasma glucose, homeostasis model assessment of insulin resistance [HOMA-IR], and lipid parameters) did not vary across the groups (p>0.05). The PHPT group had a FIB-4 index value of 0.99 (0.36–1.51), and the control group 0.66 (0.41– 1.57) (p=0.030). The number of patients in the medium-high risk category was higher in the PHPT group than in the control group (p=0.040). Conclusion: PHPT patients showed higher FIB-4 index values and a greater frequency of medium-to-high non-invasive fibrosis risk than controls. However, as FIB-4 is an indirect surrogate marker, these findings should not be interpreted as confirmed hepatic fibrosis. Further prospective studies using direct or imaging-based methods are warranted.
- 12 August 2026
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 28 (2) , 341-350
FIB-4 INDEX IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: A CASE-CONTROL STUDY
Objective: Although the target organs for primary hyperparathyroidism (PHPT) are the renal and skeletal systems, hyperparathyroidism has also been linked with metabolic syndrome as well as non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate metabolic parameters, and the fibrosis-4 index (FIB-4) among patients with PHPT. Material and Methods: This study included 30 patients with PHPT and 30 healthy controls. FIB-4 index was calculated for all participants whose metabolic parameters were recorded. In addition, according to the FIB-4 index, participants were divided into low and medium-high risk categories for fibrosis using a cut-off value of 1.3. The participants’ metabolic parameters and the FIB-4 indices were compared. Results: PHPT patients had a median age of 58 years (25–65), and 90% of them were female. Metabolic parameters (fasting plasma glucose, homeostasis model assessment of insulin resistance [HOMA-IR], and lipid parameters) did not vary across the groups (p>0.05). The PHPT group had a FIB-4 index value of 0.99 (0.36–1.51), and the control group 0.66 (0.41– 1.57) (p=0.030). The number of patients in the medium-high risk category was higher in the PHPT group than in the control group (p=0.040). Conclusion: PHPT patients showed higher FIB-4 index values and a greater frequency of medium-to-high non-invasive fibrosis risk than controls. However, as FIB-4 is an indirect surrogate marker, these findings should not be interpreted as confirmed hepatic fibrosis. Further prospective studies using direct or imaging-based methods are warranted.
- Open Access
- 31 July 2026
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 6 (3) , 225-235
Cognitive performance in chronic postoperative hypoparathyroidism: A cross-sectional study
Objective: To evaluate cognitive performance in patients with chronic postoperative hypoparathyroidism and to investigate its association with biochemical parameters.Methods: This prospective, observational, cross-sectional study included 56 patients aged 40–65 years with chronic postoperative hypoparathyroidism, 28 post-thyroidectomy hypothyroid patients without hypoparathyroidism, and 28 healthy controls. Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Biochemical parameters, including albumin-corrected serum calcium and intact parathyroid hormone (iPTH), were measured concurrently. Multivariable analyses were performed to identify independent determinants of cognitive performance.Results: Although no significant differences were observed among the groups in terms of total MMSE scores, selective differences were detected in the registration and language subdomains in patients with chronic postoperative hypoparathyroidism. Albumin-corrected serum calcium levels and age independently predicted language performance. In addition, a positive correlation was identified between iPTH levels and registration memory scores.Conclusion: Chronic postoperative hypoparathyroidism may be associated with mild, domain-specific cognitive alterations rather than global cognitive decline. The association of albumin-corrected serum calcium and age with language performance suggests a potential role of calcium homeostasis in cognitive function. Cognitive assessment may therefore be considered as part of long-term follow-up in these patients.
- 31 July 2026
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 6 (3) , 225-235
Open AccessCognitive performance in chronic postoperative hypoparathyroidism: A cross-sectional study
Objective: To evaluate cognitive performance in patients with chronic postoperative hypoparathyroidism and to investigate its association with biochemical parameters.Methods: This prospective, observational, cross-sectional study included 56 patients aged 40–65 years with chronic postoperative hypoparathyroidism, 28 post-thyroidectomy hypothyroid patients without hypoparathyroidism, and 28 healthy controls. Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Biochemical parameters, including albumin-corrected serum calcium and intact parathyroid hormone (iPTH), were measured concurrently. Multivariable analyses were performed to identify independent determinants of cognitive performance.Results: Although no significant differences were observed among the groups in terms of total MMSE scores, selective differences were detected in the registration and language subdomains in patients with chronic postoperative hypoparathyroidism. Albumin-corrected serum calcium levels and age independently predicted language performance. In addition, a positive correlation was identified between iPTH levels and registration memory scores.Conclusion: Chronic postoperative hypoparathyroidism may be associated with mild, domain-specific cognitive alterations rather than global cognitive decline. The association of albumin-corrected serum calcium and age with language performance suggests a potential role of calcium homeostasis in cognitive function. Cognitive assessment may therefore be considered as part of long-term follow-up in these patients.
- 17 June 2026
- Published by Necmettin Erbakan University in Selcuk Tip Dergisi
Diagnostic Value of Preoperative Imaging Modalities and Their Association with Clinical Parameters in Lesion Localization in Primary Hyperparathyroidism
Amaç: Primer hiperparatiroidizmde preoperatif görüntüleme yöntemlerinin tanısal değerini değerlendirmek ve lokalizasyon başarısı ile klinik ve biyokimyasal özellikler arasındaki ilişkiyi incelemek. Gereç ve Yöntemler: Primer hiperparatiroidizm nedeniyle paratiroidektomiye giden ve preoperatif dönemde başlangıçta lokalizasyon amaçlı boyun ultrasonografisi ve Tc-99m sestamibi sintigrafisi yapılmış 216 hastanın verileri retrospektif olarak analiz edildi. Başlangıç görüntüleme yöntemleriyle lokalize edilemeyen olgular, 4-boyutlu BT ve/veya 18F-kolin PET-BT raporları temel alınarak değerlendirildi. Görüntüleme yöntemlerinin doğru lokalizasyon sonuçları ile klinik ve biyokimyasal özellikler arasındaki ilişkiler analiz edildi. Bulgular: Boyun ultrasonografisi ve Tc-99m sestamibi sintigrafisinin kombine kullanımı, hiperfonksiyonel lezyonların saptanmasında %55,1 duyarlılık ve %96,3 pozitif prediktif değer göstermiştir. Çok değişkenli analizde ise, paratiroid bez boyutunun >1 cm olması (OR=2,521, p=0,002), serum iPTH düzeyinin >134 ng/L olması (OR=2,270, p=0,007) ve normokalsemik primer hiperparatiroidizm varlığı (OR=2,546, p=0,023), kombine USG ve sestamibi sintigrafisi ile başarılı lokalizasyonun bağımsız belirleyicileri olarak saptanmıştır. Sonuç: Kombine boyun ultrasonografisi ve Tc-99m sestamibi sintigrafisi, özellikle daha büyük bez boyutu, yüksek iPTH düzeyleri ve normokalsemik primer hiperparatiroidizm varlığında etkili olup, seçilmiş hastalarda ileri görüntüleme yöntemlerine olan gereksinimi ortadan kaldırabilir.
- 17 June 2026
- Published by Necmettin Erbakan University in Selcuk Tip Dergisi
Diagnostic Value of Preoperative Imaging Modalities and Their Association with Clinical Parameters in Lesion Localization in Primary Hyperparathyroidism
Amaç: Primer hiperparatiroidizmde preoperatif görüntüleme yöntemlerinin tanısal değerini değerlendirmek ve lokalizasyon başarısı ile klinik ve biyokimyasal özellikler arasındaki ilişkiyi incelemek. Gereç ve Yöntemler: Primer hiperparatiroidizm nedeniyle paratiroidektomiye giden ve preoperatif dönemde başlangıçta lokalizasyon amaçlı boyun ultrasonografisi ve Tc-99m sestamibi sintigrafisi yapılmış 216 hastanın verileri retrospektif olarak analiz edildi. Başlangıç görüntüleme yöntemleriyle lokalize edilemeyen olgular, 4-boyutlu BT ve/veya 18F-kolin PET-BT raporları temel alınarak değerlendirildi. Görüntüleme yöntemlerinin doğru lokalizasyon sonuçları ile klinik ve biyokimyasal özellikler arasındaki ilişkiler analiz edildi. Bulgular: Boyun ultrasonografisi ve Tc-99m sestamibi sintigrafisinin kombine kullanımı, hiperfonksiyonel lezyonların saptanmasında %55,1 duyarlılık ve %96,3 pozitif prediktif değer göstermiştir. Çok değişkenli analizde ise, paratiroid bez boyutunun >1 cm olması (OR=2,521, p=0,002), serum iPTH düzeyinin >134 ng/L olması (OR=2,270, p=0,007) ve normokalsemik primer hiperparatiroidizm varlığı (OR=2,546, p=0,023), kombine USG ve sestamibi sintigrafisi ile başarılı lokalizasyonun bağımsız belirleyicileri olarak saptanmıştır. Sonuç: Kombine boyun ultrasonografisi ve Tc-99m sestamibi sintigrafisi, özellikle daha büyük bez boyutu, yüksek iPTH düzeyleri ve normokalsemik primer hiperparatiroidizm varlığında etkili olup, seçilmiş hastalarda ileri görüntüleme yöntemlerine olan gereksinimi ortadan kaldırabilir.
- Open Access
- 12 May 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1825381
A novel marker for predicting malignancy in patients with thyroid nodules diagnosed as AUS on initial cytology: thyroid hormone sensitivity
Purpose: This study aimed to evaluate the predictive value of thyroid hormone sensitivity indices and hematological inflammatory markers, in addition to ultrasonographic features, for malignancy in thyroid nodules initially classified as atypia of undetermined significance (AUS). Methods: Data from 415 thyroid nodules initially diagnosed as Bethesda category III (AUS) on fine-needle aspiration biopsy (FNAB) were retrospectively analyzed. Nodules with benign histopathology or benign cytology on repeat FNAB were classified as the benign group, whereas those with malignant histopathology were classified as the malignant group. The groups were compared in terms of ultrasonographic features, baseline hematological parameters, and thyroid hormone sensitivity indices. Results: A total of 185 patients with thyroid nodules initially classified as Bethesda category III (AUS) were included, and 30.8% of surgically treated cases were malignant. A family history of thyroid cancer was more frequent in the malignant group (26.3% vs 10.9%, p=0.008). Malignant nodules were more likely to be solid, hypoechoic, and associated with microcalcifications, irregular margins, intranodular vascularity, and higher EU-TIRADS categories (all p<0.05). TSH and thyroid hormone sensitivity indices (TT4RI, TSHI, TFQI) were significantly higher in malignant nodules. In multivariable analysis, suspicious EU-TIRADS classification, family history of thyroid cancer, intranodular vascularity, PLR-to-PDW ratio, and thyroid hormone sensitivity indices remained independent predictors of malignancy. ROC analysis demonstrated moderate diagnostic performance for TSHI and TT4RI. Conclusion: Thyroid hormone sensitivity indices may serve as adjunctive markers for malignancy risk stratification in Bethesda category III thyroid nodules and may complement ultrasonographic assessment in clinical decision-making.
- 12 May 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1825381
Open AccessA novel marker for predicting malignancy in patients with thyroid nodules diagnosed as AUS on initial cytology: thyroid hormone sensitivity
Purpose: This study aimed to evaluate the predictive value of thyroid hormone sensitivity indices and hematological inflammatory markers, in addition to ultrasonographic features, for malignancy in thyroid nodules initially classified as atypia of undetermined significance (AUS). Methods: Data from 415 thyroid nodules initially diagnosed as Bethesda category III (AUS) on fine-needle aspiration biopsy (FNAB) were retrospectively analyzed. Nodules with benign histopathology or benign cytology on repeat FNAB were classified as the benign group, whereas those with malignant histopathology were classified as the malignant group. The groups were compared in terms of ultrasonographic features, baseline hematological parameters, and thyroid hormone sensitivity indices. Results: A total of 185 patients with thyroid nodules initially classified as Bethesda category III (AUS) were included, and 30.8% of surgically treated cases were malignant. A family history of thyroid cancer was more frequent in the malignant group (26.3% vs 10.9%, p=0.008). Malignant nodules were more likely to be solid, hypoechoic, and associated with microcalcifications, irregular margins, intranodular vascularity, and higher EU-TIRADS categories (all p<0.05). TSH and thyroid hormone sensitivity indices (TT4RI, TSHI, TFQI) were significantly higher in malignant nodules. In multivariable analysis, suspicious EU-TIRADS classification, family history of thyroid cancer, intranodular vascularity, PLR-to-PDW ratio, and thyroid hormone sensitivity indices remained independent predictors of malignancy. ROC analysis demonstrated moderate diagnostic performance for TSHI and TT4RI. Conclusion: Thyroid hormone sensitivity indices may serve as adjunctive markers for malignancy risk stratification in Bethesda category III thyroid nodules and may complement ultrasonographic assessment in clinical decision-making.
- 30 April 2026
- Published by Springer Nature in Pituitary
- Vol. 29 (3) , 80
Decision-making and impulsivity in cabergoline-treated prolactinoma: findings from Iowa Gambling, Go/No-Go, and barratt scales
- 30 April 2026
- Published by Springer Nature in Pituitary
- Vol. 29 (3) , 80
Decision-making and impulsivity in cabergoline-treated prolactinoma: findings from Iowa Gambling, Go/No-Go, and barratt scales
- Open Access
- 27 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
The Digital Landscape of Hypothyroidism on YouTube: A Comprehensive Analysis of Viewing Trends, Sentiment, Network Dynamics, and Content Creator Influence (Preprint)
BACKGROUND Hypothyroidism affects approximately 5% of the global population. While YouTube has emerged as a dominant health information platform, the specific network dynamics and information flow regarding chronic thyroid disease remain largely unexplored in digital health research. OBJECTIVE The objective of this study was to conduct a comprehensive infodemiological analysis of hypothyroidism content on YouTube, evaluating temporal trends, network structures, and audience sentiment across different creator categories. METHODS We identified 331 hypothyroidism-related YouTube videos (2015-2025). For creator-type comparisons, we excluded 18 videos from channels with unknown creator classification, yielding a filtered dataset of 313 videos (medical n=251; influencer n=62). Descriptive analyses used the full dataset (N=331), whereas inferential comparisons used the filtered dataset (n=313).The methodology integrated engagement analytics, The Valence Aware Dictionary and sEntiment Reasoner(VADER) sentiment analysis (validated via manual coding, κ=0.87), and social network analysis using NetworkX to construct bipartite graphs of the information ecosystem. Statistical comparisons were performed using Mann-Whitney U tests and Cohen d effect sizes. RESULTS Medical channels dominated content production (80.2%). Despite numerical differences in raw metrics, medical and influencer content demonstrated equivalent engagement rates (2.24% vs 2.36%; P=.31; d=-0.091), suggesting that engagement quality is independent of creator credentials. The COVID-19 pandemic catalyzed a 234% increase in content volume, resulting in a sustained elevation of post-pandemic engagement (2.47% vs 1.70% pre-pandemic). Network analysis revealed distinct structural models: medical networks followed a distributed expertise model (density=0.0151), whereas influencer networks utilized hub-centric approaches (density=0.0368). Sentiment analyses included 40,260 comments in the full dataset; creator-type stratified analyses included 38,495 comments after excluding unknown channels. Overall sentiment was predominantly positive (47.3%), though mean sentiment scores significantly declined from pre-pandemic optimism (0.270) to post-pandemic skepticism (0.183). Key information hubs identified included Dr. Westin Childs (medical centrality=0.189) and Fit Tuber (8.1M subscribers). CONCLUSIONS This study demonstrates that engagement quality in thyroid health communication transcends traditional creator credentials. The pandemic has permanently transformed digital health consumption patterns, establishing YouTube as a resilient resource for chronic disease information while challenging prevailing assumptions regarding the dominance of health misinformation.
- 27 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Digital Landscape of Hypothyroidism on YouTube: A Comprehensive Analysis of Viewing Trends, Sentiment, Network Dynamics, and Content Creator Influence (Preprint)
BACKGROUND Hypothyroidism affects approximately 5% of the global population. While YouTube has emerged as a dominant health information platform, the specific network dynamics and information flow regarding chronic thyroid disease remain largely unexplored in digital health research. OBJECTIVE The objective of this study was to conduct a comprehensive infodemiological analysis of hypothyroidism content on YouTube, evaluating temporal trends, network structures, and audience sentiment across different creator categories. METHODS We identified 331 hypothyroidism-related YouTube videos (2015-2025). For creator-type comparisons, we excluded 18 videos from channels with unknown creator classification, yielding a filtered dataset of 313 videos (medical n=251; influencer n=62). Descriptive analyses used the full dataset (N=331), whereas inferential comparisons used the filtered dataset (n=313).The methodology integrated engagement analytics, The Valence Aware Dictionary and sEntiment Reasoner(VADER) sentiment analysis (validated via manual coding, κ=0.87), and social network analysis using NetworkX to construct bipartite graphs of the information ecosystem. Statistical comparisons were performed using Mann-Whitney U tests and Cohen d effect sizes. RESULTS Medical channels dominated content production (80.2%). Despite numerical differences in raw metrics, medical and influencer content demonstrated equivalent engagement rates (2.24% vs 2.36%; P=.31; d=-0.091), suggesting that engagement quality is independent of creator credentials. The COVID-19 pandemic catalyzed a 234% increase in content volume, resulting in a sustained elevation of post-pandemic engagement (2.47% vs 1.70% pre-pandemic). Network analysis revealed distinct structural models: medical networks followed a distributed expertise model (density=0.0151), whereas influencer networks utilized hub-centric approaches (density=0.0368). Sentiment analyses included 40,260 comments in the full dataset; creator-type stratified analyses included 38,495 comments after excluding unknown channels. Overall sentiment was predominantly positive (47.3%), though mean sentiment scores significantly declined from pre-pandemic optimism (0.270) to post-pandemic skepticism (0.183). Key information hubs identified included Dr. Westin Childs (medical centrality=0.189) and Fit Tuber (8.1M subscribers). CONCLUSIONS This study demonstrates that engagement quality in thyroid health communication transcends traditional creator credentials. The pandemic has permanently transformed digital health consumption patterns, establishing YouTube as a resilient resource for chronic disease information while challenging prevailing assumptions regarding the dominance of health misinformation.
- Open Access
- 1 January 2025
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 59 (1) , 143
Reply to Letter to the Editor: "ChatGPT-4 Performance in Answering Patients' Questions About the Management of Type 2 Diabetes: Correspondence"
The Medical Bulletin of Sisli Etfal Hospital
- 1 January 2025
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 59 (1) , 143
Open AccessReply to Letter to the Editor: "ChatGPT-4 Performance in Answering Patients' Questions About the Management of Type 2 Diabetes: Correspondence"
The Medical Bulletin of Sisli Etfal Hospital
- 1 July 2024
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 24 (9) , 1120-1125
A Case Presenting with Neck Pain and High Sedimentation Rate: Amyloid Goiter
Introduction: Amyloid goiter is a rare disease characterized by amyloid deposits that cause sudden growth in the thyroid gland. Case Presentation: Here we present a case of a 26-year-old woman with euthyroid amyloid goiter who presented with subacute granulomatous thyroiditis clinic. Amyloid goiter was detected as a result of core biopsy from the thyroid parenchyma of the patient with sudden thyroid enlargement. Surgery was not applied to the patient who had no pressure symptoms or signs. In systemic amyloidosis secondary to Familial Mediterranean fever, heart and kidney involvement, as well as the thyroid gland, were detected. Conclusion: Amyloid accumulation should be considered in addition to anaplastic thyroid cancer and lymphoma in patients with sudden thyroid enlargement. It should not be overlooked that amyloid goiter may mimic subacute thyroiditis clinic. Systemic amyloidosis should be considered in patients with amyloid goiter, and an examination should be made to assess the presence of amyloid accumulations in other organs.
- 1 July 2024
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 24 (9) , 1120-1125
A Case Presenting with Neck Pain and High Sedimentation Rate: Amyloid Goiter
Introduction: Amyloid goiter is a rare disease characterized by amyloid deposits that cause sudden growth in the thyroid gland. Case Presentation: Here we present a case of a 26-year-old woman with euthyroid amyloid goiter who presented with subacute granulomatous thyroiditis clinic. Amyloid goiter was detected as a result of core biopsy from the thyroid parenchyma of the patient with sudden thyroid enlargement. Surgery was not applied to the patient who had no pressure symptoms or signs. In systemic amyloidosis secondary to Familial Mediterranean fever, heart and kidney involvement, as well as the thyroid gland, were detected. Conclusion: Amyloid accumulation should be considered in addition to anaplastic thyroid cancer and lymphoma in patients with sudden thyroid enlargement. It should not be overlooked that amyloid goiter may mimic subacute thyroiditis clinic. Systemic amyloidosis should be considered in patients with amyloid goiter, and an examination should be made to assess the presence of amyloid accumulations in other organs.
- Open Access
- 30 April 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (2) , 113-120
Evaluation of patient satisfaction following oral glucose tolerance test
Aim: Diabetes mellitus (DM) is a common metabolic disease. Early diagnosis of diabetes prevents the increase in mortality and morbidity due to complications. The oral glucose tolerance test (OGTT) is a test used in the diagnosis of DM and in the determination of impaired glucose tolerance (IGT). In our study, it was aimed to evaluate the satisfaction of patients who underwent OGTT. Methods: A 25-question questionnaire was applied to 300 patients who underwent OGTT, aiming to evaluate their satisfaction. The physical and psychological status of the patients was examined before, during, and after the test. Results: Patients who were informed about the test before the test experienced less nausea during fluid intake (p=0.005). Approximately 58.7% of the participants agreed to repeat the test. Those who felt nauseous or hungry during the test were statistically less likely to accept retesting. The retest acceptance rates were statistically higher (p<0.05) among individuals who did not feel uncomfortable with the blood draw and inactivity and who did not vomit or feel uneasy during the test. 70% of the participants answered 'yes' to the suggestion of using an alternative diagnostic method. Conclusion: OGTT is the gold standard for the diagnosis of IGT and DM, despite tests such as HbA1c and fasting plasma glucose, which are more easily performed and practical. It would be beneficial to develop another method that is easy to apply, better tolerated by patients, easy to repeat, and can be standardized instead of OGTT.
- 30 April 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (2) , 113-120
Open AccessEvaluation of patient satisfaction following oral glucose tolerance test
Aim: Diabetes mellitus (DM) is a common metabolic disease. Early diagnosis of diabetes prevents the increase in mortality and morbidity due to complications. The oral glucose tolerance test (OGTT) is a test used in the diagnosis of DM and in the determination of impaired glucose tolerance (IGT). In our study, it was aimed to evaluate the satisfaction of patients who underwent OGTT. Methods: A 25-question questionnaire was applied to 300 patients who underwent OGTT, aiming to evaluate their satisfaction. The physical and psychological status of the patients was examined before, during, and after the test. Results: Patients who were informed about the test before the test experienced less nausea during fluid intake (p=0.005). Approximately 58.7% of the participants agreed to repeat the test. Those who felt nauseous or hungry during the test were statistically less likely to accept retesting. The retest acceptance rates were statistically higher (p<0.05) among individuals who did not feel uncomfortable with the blood draw and inactivity and who did not vomit or feel uneasy during the test. 70% of the participants answered 'yes' to the suggestion of using an alternative diagnostic method. Conclusion: OGTT is the gold standard for the diagnosis of IGT and DM, despite tests such as HbA1c and fasting plasma glucose, which are more easily performed and practical. It would be beneficial to develop another method that is easy to apply, better tolerated by patients, easy to repeat, and can be standardized instead of OGTT.
- Open Access
- 30 April 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (2) , 113-120
Evaluation of patient satisfaction following oral glucose tolerance test
Aim: Diabetes mellitus (DM) is a common metabolic disease. Early diagnosis of diabetes prevents the increase in mortality and morbidity due to complications. The oral glucose tolerance test (OGTT) is a test used in the diagnosis of DM and in the determination of impaired glucose tolerance (IGT). In our study, it was aimed to evaluate the satisfaction of patients who underwent OGTT. Methods: A 25-question questionnaire was applied to 300 patients who underwent OGTT, aiming to evaluate their satisfaction. The physical and psychological status of the patients was examined before, during, and after the test. Results: Patients who were informed about the test before the test experienced less nausea during fluid intake (p=0.005). Approximately 58.7% of the participants agreed to repeat the test. Those who felt nauseous or hungry during the test were statistically less likely to accept retesting. The retest acceptance rates were statistically higher (p<0.05) among individuals who did not feel uncomfortable with the blood draw and inactivity and who did not vomit or feel uneasy during the test. 70% of the participants answered 'yes' to the suggestion of using an alternative diagnostic method. Conclusion: OGTT is the gold standard for the diagnosis of IGT and DM, despite tests such as HbA1c and fasting plasma glucose, which are more easily performed and practical. It would be beneficial to develop another method that is easy to apply, better tolerated by patients, easy to repeat, and can be standardized instead of OGTT.
- 30 April 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (2) , 113-120
Open AccessEvaluation of patient satisfaction following oral glucose tolerance test
Aim: Diabetes mellitus (DM) is a common metabolic disease. Early diagnosis of diabetes prevents the increase in mortality and morbidity due to complications. The oral glucose tolerance test (OGTT) is a test used in the diagnosis of DM and in the determination of impaired glucose tolerance (IGT). In our study, it was aimed to evaluate the satisfaction of patients who underwent OGTT. Methods: A 25-question questionnaire was applied to 300 patients who underwent OGTT, aiming to evaluate their satisfaction. The physical and psychological status of the patients was examined before, during, and after the test. Results: Patients who were informed about the test before the test experienced less nausea during fluid intake (p=0.005). Approximately 58.7% of the participants agreed to repeat the test. Those who felt nauseous or hungry during the test were statistically less likely to accept retesting. The retest acceptance rates were statistically higher (p<0.05) among individuals who did not feel uncomfortable with the blood draw and inactivity and who did not vomit or feel uneasy during the test. 70% of the participants answered 'yes' to the suggestion of using an alternative diagnostic method. Conclusion: OGTT is the gold standard for the diagnosis of IGT and DM, despite tests such as HbA1c and fasting plasma glucose, which are more easily performed and practical. It would be beneficial to develop another method that is easy to apply, better tolerated by patients, easy to repeat, and can be standardized instead of OGTT.